Literature DB >> 6329071

Contralateral cerebellar hypometabolism following cerebral insult: a positron emission tomographic study.

M Kushner, A Alavi, M Reivich, R Dann, A Burke, G Robinson.   

Abstract

Positron emission tomographic studies of 16 patients with cerebral ischemia and brain tumor showed asymmetries in cerebellar metabolism not encountered in 14 normal control subjects. An asymmetry was present in 62.5% of cases. The lower metabolic rate occurred in the cerebellar hemisphere contralateral to the cerebral lesion (p less than 0.001; sign test). In all cases computed tomography showed the supratentorial lesion to be unilateral and the posterior fossa contents to be unaffected. The presence of depressed cerebellar metabolism was highly associated with involvement of the contralateral parietal lobe (p less than 0.02; phi coefficient). The presence of a cerebellar abnormality was not related to the presence of any particular sign. Serial studies showed normalization of cerebellar metabolism over time. It is likely that this effect is a result of interruption of the functional interconnections between the cerebrum and the cerebellum.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6329071     DOI: 10.1002/ana.410150505

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  21 in total

1.  High resolution SPECT, small deep infarcts and diaschisis.

Authors:  J V Bowler; D C Costa; B E Jones; T J Steiner; J P Wade
Journal:  J R Soc Med       Date:  1992-03       Impact factor: 5.344

2.  99mTc-hexamethylpropylene amine oxime SPECT and X-ray CT in acute cerebral ischaemia.

Authors:  M Feldmann; E Voth; D Dressler; T Henze; K Felgenhauer
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

3.  Cerebral diaschisis in patients with malignant glioma.

Authors:  J M Rozental; R L Levine; R J Nickles; J A Dobkin; J M Hanson
Journal:  J Neurooncol       Date:  1990-04       Impact factor: 4.130

4.  Prognostic value of subacute crossed cerebellar diaschisis: single-photon emission CT study in patients with middle cerebral artery territory infarct.

Authors:  Masashi Takasawa; Manabu Watanabe; Shiro Yamamoto; Taku Hoshi; Tsutomu Sasaki; Kazuo Hashikawa; Masayasu Matsumoto; Naokazu Kinoshita
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

Review 5.  Extensive metabolic and neuropsychological abnormalities associated with discrete infarction of the genu of the internal capsule.

Authors:  F E Chukwudelunzu; J F Meschia; N R Graff-Radford; J A Lucas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

6.  Cerebellar diaschisis in pontine infarctions: a report of five cases.

Authors:  Y Tsuda; Y Ayada; Y Izumi; S Ichihara; N Hosomi; M Ohkawa; H Matsuo
Journal:  Eur J Nucl Med       Date:  1995-05

7.  Remote effects in the ipsilateral thalamus and/or contralateral cerebellar hemisphere using FDG PET in patients with brain tumors.

Authors:  Hitomi Iwasa; Yoriko Murata; Miki Nishimori; Kana Miyatake; Michiko Tadokoro; Shino Kohsaki; Munenobu Nogami; Yusuke Ueba; Tetsuya Ueba; Takuji Yamagami
Journal:  Jpn J Radiol       Date:  2018-01-25       Impact factor: 2.374

8.  Exploring temporospatial changes in glucose metabolic disorder, learning, and memory dysfunction in a rat model of diffuse axonal injury.

Authors:  Jia Li; Lei Gu; Dong-Fu Feng; Fang Ding; Guangyao Zhu; Jiandong Rong
Journal:  J Neurotrauma       Date:  2012-11-20       Impact factor: 5.269

9.  Cerebrocerebellar relationships in normal subjects and patients with dementia of the Alzheimer type: a SPECT study.

Authors:  H Hanyu; H Arai; S Abe; T Iwamoto; M Takasaki; H Katsunuma; T Suzuki; K Abe; S Amino
Journal:  Ann Nucl Med       Date:  1993-02       Impact factor: 2.668

10.  Evaluation of technetium-99m exametazime stabilised with cobalt chloride as a blood flow tracer in focal cerebral ischaemia.

Authors:  G Gartshore; P Bannan; J Patterson; B Higley; J McCulloch
Journal:  Eur J Nucl Med       Date:  1994-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.